Pandemic Puts Pressure on FDA on RWD

June 30, 2020

The COVID-19 pandemic has put increased pressure on the Food and Drug Administration’s real-world data initiatives.

According to a Pink Sheet report, the agency is set to hear from stakeholders on its data plans.

To read the report, click here.(Paid subscription required)

Share This Story!